NCT02783937View on ClinicalTrials.gov

Filgrastim for Premature Ovarian Insufficiency

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

June 30, 2021

Conditions
Premature Ovarian Failure
Interventions
BIOLOGICAL

Filgrastim

"Each case will have two intervention phases done blindly at random with a wash-out period of 6 months:~Phase A:~Filgrastim vial (30 million IU/ml) SC injection twice daily for five consecutive days.~Phase B:~Injection of saline SC injection twice daily for five consecutive days."

DRUG

Saline

Injection of saline SC injection twice daily for five consecutive days

All Listed Sponsors
lead

South Valley University

OTHER

NCT02783937 - Filgrastim for Premature Ovarian Insufficiency | Biotech Hunter | Biotech Hunter